foxo4-dri cancer Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) FOXO4-DRI 10mg
FOXO4 DRI 10mg FOXO4 DRI Peptide 10 mg The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




